NEW DIRECTIONS FOR BREAST-CANCER THERAPEUTIC RESEARCH

被引：6
作者：
FRIEDMAN, MA
机构：
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1994年 / 8卷 / 01期
关键词：
D O I：
10.1016/S0889-8588(18)30190-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：113 / 119
页数：7
相关论文
共 18 条
  • [1] CHOU TC, 1993, P AM ASS CANCER RES
  • [2] Fisherman J., 1992, P AM SOC CLIN ONCOL, V11, P57
  • [3] GOLDHIRSCH A, P AM SOC CLIN ONCOL, P76
  • [4] PHASE-II TRIAL OF TAXOL, AN ACTIVE-DRUG IN THE TREATMENT OF METASTATIC BREAST-CANCER
    HOLMES, FA
    WALTERS, RS
    THERIAULT, RL
    FORMAN, AD
    NEWTON, LK
    RABER, MN
    BUZDAR, AU
    FRYE, DK
    HORTOBAGYI, GN
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (24) : 1797 - 1805
  • [5] HOLMES FA, 1992, P AN M AM SOC CLIN, V11, P60
  • [6] IZZO J, P AM SOC CLIN ONCOL, P71
  • [7] LORUSSO P, 1992, 2ND P NAT CANC I WOR
  • [8] COLLATERAL DRUG SENSITIVITY INDUCED IN CPT-11 (A NOVEL DERIVATIVE OF CAMPTOTHECIN)-RESISTANT CELL-LINES
    OGURO, M
    SEKI, Y
    OKADA, K
    ANDOH, T
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 1990, 44 (04) : 209 - 216
  • [9] SCHIFF PB, 1981, BRISTOL MYERS CANCER, V2, P4834
  • [10] PHASE-II STUDY OF EDATREXATE IN CHEMOTHERAPY-NAIVE PATIENTS WITH METASTATIC BREAST-CANCER
    SCHORNAGEL, JH
    VANDERVEGT, S
    VERWEIJ, J
    DEGRAEFF, A
    DULLEMONDWESTLAND, A
    VANDEIJK, WA
    HUININK, WWT
    [J]. ANNALS OF ONCOLOGY, 1992, 3 (07) : 549 - 552
12